Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

100 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Recruiting

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

NCT05280509

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Gabrail Cancer Center Canton, Ohio, United States
  • University of Cincinnati (UC) Cincinnati, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 19 locations
View Trial Details
Active, not recruiting

Decitabine in Treating Patients With Myelofibrosis

NCT00095784

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
  • NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View all 14 locations
View Trial Details
Active, not recruiting

CINC424A2X01B Rollover Protocol

NCT02386800

Conditions
Acute Myeloid Leukemia, Anemia, Anemia, Hemolytic, +31 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Herston, Queensland, Australia
  • Novartis Investigative Site Wooloongabba, Queensland, Australia
  • Novartis Investigative Site Bedford Park, South Australia, Australia
View all 97 locations
View Trial Details
Active, not recruiting

P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

NCT06468033

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • University of Yamanashi Hospital Chūō, Yamanashi, Japan
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 73 locations
View Trial Details
Active, not recruiting

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

NCT04603495

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 156 locations
View Trial Details
Active, not recruiting

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions

NCT04717414

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +5 more
Locations
  • Local Institution - 110 Los Angeles, California, United States
  • Local Institution - 135 Orlando, Florida, United States
  • Local Institution - 133 Plantation, Florida, United States
  • Local Institution - 112 Chicago, Illinois, United States
View all 185 locations
View Trial Details
Active, not recruiting

Extended Access of Momelotinib in Adults With Myelofibrosis

NCT03441113

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Orange, California, United States
  • GSK Investigational Site Stanford, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
View all 112 locations
View Trial Details
Active, not recruiting

Study of Canakinumab in Patients With Myelofibrosis

NCT05467800

Conditions
Bone Marrow Diseases, ET-MF, Hematologic Diseases, +6 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Kansas Cancer Center-Westwood Westwood, Kansas, United States
  • Ruttenberg Treatment Center New York, United States
View Trial Details

Related conditions